These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 7962351

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Adenomas of the colon: overexpression of p53 protein and risk factors.
    Speroni AH, Vanzulli SI, Meiss RP.
    Endoscopy; 1998 Sep; 30(7):623-6. PubMed ID: 9826142
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
    Herman V, Drazin NZ, Gonsky R, Melmed S.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
    [Abstract] [Full Text] [Related]

  • 26. Epidemiology and pathogenesis of pituitary adenomas.
    Faglia G.
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():1-5. PubMed ID: 8396832
    [Abstract] [Full Text] [Related]

  • 27. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
    Kasuki Jomori de Pinho L, Vieira Neto L, Armondi Wildemberg LE, Gasparetto EL, Marcondes J, de Almeida Nunes B, Takiya CM, Gadelha MR.
    Neuroendocrinology; 2011 Jul; 94(1):39-48. PubMed ID: 21178332
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, Patey M, Mazucca M, Decullier E, Vergès B, Chabre O, Calender A, Groupe d'études des Tumeurs Endocrines.
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [Abstract] [Full Text] [Related]

  • 30. [Pituitary atypical adenoma or malignant corticotrophinoma?].
    Alves M, Paiva I, Belo F, Rebelo O, Bastos M, Carvalheiro M.
    Acta Med Port; 2011 Dec; 24 Suppl 3():661-6. PubMed ID: 22856408
    [Abstract] [Full Text] [Related]

  • 31. [Etiopathogenesis of pituitary tumors].
    Morange-Ramos I, Pellegrini I, Caccavelli L, Brue T, Enjalbert A, Jaquet P.
    Ann Endocrinol (Paris); 1994 Dec; 55(1):25-32. PubMed ID: 7802423
    [Abstract] [Full Text] [Related]

  • 32. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
    Ohue M, Tomita N, Monden T, Fujita M, Fukunaga M, Takami K, Yana I, Ohnishi T, Enomoto T, Inoue M.
    Cancer Res; 1994 Sep 01; 54(17):4798-804. PubMed ID: 8062281
    [Abstract] [Full Text] [Related]

  • 33. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W, Lüdecke B, Lüdecke DK.
    Exp Clin Endocrinol Diabetes; 2008 Feb 01; 116(2):80-5. PubMed ID: 18072009
    [Abstract] [Full Text] [Related]

  • 34. Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas.
    Tominaga O, Hamelin R, Trouvat V, Salmon RJ, Lesec G, Thomas G, Remvikos Y.
    Oncogene; 1993 Oct 01; 8(10):2653-8. PubMed ID: 8378077
    [Abstract] [Full Text] [Related]

  • 35. CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation.
    Xu Y, Wang Y, Ma G, Wang Q, Wei G.
    J Neurooncol; 2014 Feb 01; 116(3):625-32. PubMed ID: 24420924
    [Abstract] [Full Text] [Related]

  • 36. A clinico-pathologic study of pituitary adenomas.
    Sarkar C, Roy S, Kochupillai N, Gupta N, Tandon PN.
    Indian J Med Res; 1990 Oct 01; 92():315-23. PubMed ID: 2272669
    [Abstract] [Full Text] [Related]

  • 37. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness.
    LeRiche VK, Asa SL, Ezzat S.
    J Clin Endocrinol Metab; 1996 Feb 01; 81(2):656-62. PubMed ID: 8636285
    [Abstract] [Full Text] [Related]

  • 38. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
    Knappe UJ, Hagel C, Lisboa BW, Wilczak W, Lüdecke DK, Saeger W.
    Acta Neuropathol; 2003 Nov 01; 106(5):471-8. PubMed ID: 12904990
    [Abstract] [Full Text] [Related]

  • 39. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
    Esposito V, Santoro A, Minniti G, Salvati M, Innocenzi G, Lanzetta G, Cantore G.
    Neurol Sci; 2004 Dec 01; 25(5):251-6. PubMed ID: 15624082
    [Abstract] [Full Text] [Related]

  • 40. p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies.
    Reincke M, Karl M, Travis WH, Mastorakos G, Allolio B, Linehan HM, Chrousos GP.
    J Clin Endocrinol Metab; 1994 Mar 01; 78(3):790-4. PubMed ID: 8126158
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.